C17 Intrinsic Valuation and Fundamental Analysis - Corvus Pharmaceuticals Inc

C	Corvus Pharmaceuticals Inc F:C17	US
R	Rznomics Inc KOSDAQ:476830	KR
G	GCM Resources plc XMUN:LFD	UK
	Amatheon Agri Holding NV PAR:MLAAH	DE
F	Fuxing China Group Ltd SGX:AWK	CN
	Urbanimmersive Inc XTSX:UI	CA
T	Team Precision PCL SET:TEAM	TH
	Brightsphere Investment Group Inc F:2B9	US
F	Funding Circle Holdings PLC F:FCA	UK
H	Hasen-Immobilien AG XMUN:ABHA	DE
T	Task Group Holdings Ltd NZX:TSK	NZ
S	SPEAR Investments I BV F:7IO	NL
F	Fine Metal Technologies PCL SET:FMT	TH

Intrinsic Value

The intrinsic value for Corvus Pharmaceuticals Inc (C17) under the Base Case is hidden EUR. Compared with the current market price of 12.665 EUR, the stock appears hidden .

Intrinsic value calculated using DCF

Locked

Other reference points

Multiples estimate

Locked

Wall St target

€15.45

Do our valuations actually work? See backtest results .

C17 Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with C17’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price €12.67

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Corvus Pharmaceuticals Inc.

Explain Valuation